Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
Vivity is the first and only wavefront-shaping IOL with Alcon’s proprietary X-WAVE Technology
The pilot plant is focused on scaling up beverage production and will support applications
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Additional capacity broadens Grace’s fine chemical capabilities for API production
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Both organisations enter into a long- term collaboration to expand patient access in India
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Subscribe To Our Newsletter & Stay Updated
